Shigeru Yamano

2.2k citations
69 papers · 1.8k indexed · h-index 20
Topics
Pharmacogenetics and Drug Metabolism (16 papers)Drug Transport and Resistance Mechanisms (10 papers)Aldose Reductase and Taurine (9 papers)

In The Last Decade

Shigeru Yamano

66 papers receiving 1.8k citations

Peers

Shigeru Yamano
Comparison fields: 5 of 109
  • Molecular Biology 762
  • Pharmacology 595
  • Biochemistry 290
  • Physiology 269
  • Oncology 267
Replace Lena Gustavsson with:
Lena Gustavsson Sweden
Plinio Richelmi Italy
Marı́a Cascales Spain
Yuji Ishii Japan
Margaret R. Davis United States
Lewis L. Smith United Kingdom
Zuzana Červinková Czechia
Theodorus P.M. Akerboom Germany
Scott A. Reisman United States
Rosella Fulceri Italy
Shigeru Yamano relative to Lena Gustavsson Sweden Lena Gustavsson's profile →
Citations per field
00.5×1.7×
Lena Gustavsson · 1×
Citations per year

Countries citing papers authored by Shigeru Yamano

Since Specialization
Citations

This map shows the geographic impact of Shigeru Yamano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeru Yamano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeru Yamano more than expected).

Fields of papers citing papers by Shigeru Yamano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeru Yamano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeru Yamano. The network helps show where Shigeru Yamano may publish in the future.

Co-authorship network of co-authors of Shigeru Yamano

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeru Yamano. A scholar is included among the top collaborators of Shigeru Yamano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeru Yamano. Shigeru Yamano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 7
3 1
4 38
5 9
6 19
7 16
8 8
9 54
10 5
11 14
12 4
13 10
14 38
15 17
16 1
17 4
18 9
19 30
20 136

About Shigeru Yamano

Shigeru Yamano is a scholar working on Pharmacology, Biochemistry and Toxicology, having authored 69 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Drug Transport and Resistance Mechanisms (10 papers) and Aldose Reductase and Taurine (9 papers). The work is most often cited by research in Pharmacology (595 citations), Biochemistry (290 citations) and Toxicology (65 citations). Shigeru Yamano has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Frank J. Gonzalez, Jun Tatsuno, Kimihiko Matsusue, Takashi Kusakabe, Toshimitsu Suzuki, Takahiro Noguchi, Yoshito Kumagai, Keiko Taguchi, Hidetoshi Yoshimura and Hidenari Shigematsu. Their work appears in journals such as Nucleic Acids Research, The Journal of Clinical Endocrinology & Metabolism and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026